TerminatedNCT04353921
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Observational studyAges 21–65United StatesDepression
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
- Listed locations
- LauderhillSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 30, 2020
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 26
- Sponsor
- Usona Institute
- Sponsor type
- Research institute
- Study type
- Observational
- Intervention type
- Other
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT04353921
- Official title
Show the full official title
A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lauderhill
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Usona Institute, a research institute.
Who can participate?
This study is for people with depression. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant
Brain Tissue Collection for Neuropathological Studies